Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares were up 3.6% during mid-day trading on Thursday . The company ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published ...

Hims & Hers Health is revolutionizing telehealth with a vertically integrated model, offering personalized medications and achieving rapid subscription growth, driving long-term profitability and ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

1 Day HIMS 1.21% DJIA 0.07% S&P 500 -0.04% Retail/Wholesale 0.01% ...

1 Day HIMS -6.77% DJIA -0.77% S&P 500 -1.11% Retail/Wholesale -0.68% Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect ...

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Buy rating on Hims & Hers Health (HIMS – Research Report). The associated price target remains the same with $42.00. Discover the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.